The IGL gene helps make the lambda light chain, one of the parts your antibodies use to recognize and attach to germs. If this gene does not work properly, your body may have trouble making some antibodies, which can weaken immune defense, and changes in this region are sometimes seen in certain blood cancers. Most people never hear about the IGL gene outside immune testing or cancer genetics.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or direct processes in the body. Some genes provide the instructions for proteins, which are the parts of cells that do much of the work. Others mainly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes influence how the body develops and works, and they can affect how you respond to food, stress, or medicines. For a closer look at this topic, you can learn more in the LearnHub.
Overview
IGLGene function
What if the gene works
The IGL gene helps B cells make the lambda part of some antibodies. These proteins recognize germs and support your immune system’s usual defense.
Risk
What if the gene does not work
Milder to more disruptive variants in the IGL gene can reduce or disrupt lambda light chain production, which forms part of an antibody. This can limit how some B cells assemble complete antibodies and may narrow antibody diversity.
Treatment
What does that mean for your treatment
No IGL-specific treatment or drug selection approach is currently established. In practice, changes involving the IGL gene region are mainly studied as disease markers in some blood cancers, where they can help classify disease or follow response rather than guide a gene targeted therapy.
Gene function
What if the gene works
The IGL gene helps your immune system build part of an antibody, a protein that recognizes germs. In B cells, which are immune cells that make antibodies, it provides the instructions for a lambda light chain. This is part of how the IGL gene helps make antibodies that can match many different targets.
The IGL gene provides instructions for the lambda light chain, one part of an antibody. When this light chain pairs with a heavy chain, your body can assemble a complete antibody.
In developing B cells, pieces of the IGL gene are mixed and matched in different ways. This lets your immune system make many antibodies that can recognize a wide range of germs and other foreign targets.
Antibodies that use a light chain from the IGL gene can attach to bacteria, viruses, and other foreign substances. This helps your immune system mark what should be cleared and supports a focused immune response.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IGL gene can change the protein building blocks of the lambda light chain or reduce how much of it a cell makes. This is one way IGL gene variants affect protein function, by altering folding, stability, target binding, or pairing with the matching heavy chain. Milder variants may cause small changes in shape or output, while more severe variants can disrupt the gene message, create a shortened chain, or stop proper assembly altogether.
How variants are linked to conditions
IGL does not yet have a broadly confirmed link to a specific health condition, although research on conditions linked to IGL gene variants may develop over time. If you have a confirmed IGL finding on genetic testing, your doctor or genetic counselor can explain what it may mean for you and your family.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to IGL. Anyone with concerns about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of IGL variants
The way IGL gene variants are inherited is not yet linked to one broadly confirmed, disease-specific Mendelian pattern. This can change as research develops and as different changes in this region are studied more clearly. The IGL gene is located on chromosome 22, which is an autosome, so you inherit one copy from each parent. In general, that means IGL gene variants can be passed down through either side of the family.
What does my IGL result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for IGL. Understanding of this gene area can change as research develops. If you have a specific IGL result and want to know what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your family history and the exact finding.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the IGL gene, a lab uses a blood or saliva sample and reads the DNA code in that area. This explains how genetic testing for IGL variants works: the lab compares your sequence with a reference sequence and reports whether a variant was found.
When should I consider getting a genetic test?
There isn't yet a broadly established, IGL-specific reason for genetic testing. Testing decisions are usually based on the bigger picture, such as personal health concerns, blood or bone marrow findings, or family history, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and the type of variant involved. Over time, lifestyle, environment, age, and medical history, among other influences, shape how the body works. For some conditions, especially those affected by many genes, genetic information gives context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, these results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person but less well for another, or why some people are more sensitive to side effects. These differences are common and are one part of the bigger picture alongside age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect response to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support more informed and personalized treatment decisions. To explore this subject in more detail, you can learn more in the LearnHub.
Drugs influenced by the IGL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so general questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.
History
IGL entered medical genetics through landmark studies of antibodies in the mid 20th century, when researchers were trying to understand how the immune system makes such a wide range of protective proteins. Inheritance patterns were noticed long before the gene was identified. Work in the 1960s and 1970s helped show that lambda light chain genes are arranged in segments, a finding that reshaped ideas about how immune genes are organized. This became part of the broader discovery that some genes in immune cells are assembled in stages rather than inherited in one fixed piece. From these first observations, research expanded steadily. Those discoveries helped lay the groundwork for modern immunology, antibody testing, and later advances in blood cancer research.